Third Pole Therapeutics Secures $15 Million Debt Facility with Avenue Venture Opportunities Fund, L.P.
Funding to Support Validation Testing of the First Tankless Inhaled Nitric Oxide (iNO) Wearable Device for Home Use WALTHAM, Mass., April 15, 2021 -- (Healthcare Sales & Marketing Network) -- Third Pole Therapeutics, a privately held company developing... Devices, Venture Capital Third Pole Therapeutics, inhaled nitric oxide, tankless iNO (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 15, 2021 Category: Pharmaceuticals Source Type: news

Vicarious Surgical Inc. and D8 Holdings Corp. Announce Definitive Business Combination Agreement
Vicarious Surgical is a next generation robotics company developing a disruptive technology with the goal of increasing the efficiency of surgical procedures, improving patient outcomes and reducing healthcare costs The transaction values the combined c... Devices, Surgery, Mergers & Acquisiitons Vicarious Surgical, robotic surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 15, 2021 Category: Pharmaceuticals Source Type: news

Valeo Pharma Announces Commercial Launch of Redesca(TM) and Redesca HP(TM)
Shipments have commenced across Canada National sales coverage in full deployment through a dedicated key account managers team Private and public reimbursement activities on target MONTREAL, April 15, 2021 -- (Healthcare Sales & Marketing Network... Biopharmaceuticals, Product Launch Valeo Pharma, Redesca , Redesca HP, heparin, biosimilar (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 15, 2021 Category: Pharmaceuticals Source Type: news

Juniper Biologics Announces the Appointment of Raman Singh as Chief Executive
Singh to lead Juniper Biologics operations from Singapore and deliver medicines in Oncology, Rare/Orphan Diseases and Gene Therapy SINGAPORE, April 15, 2021 -- (Healthcare Sales & Marketing Network) -- Juniper Biologics, a science-led healthcare compan... Biopharmaceuticals, Personnel Juniper Biologics (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 15, 2021 Category: Pharmaceuticals Source Type: news

Medtronic Announces European Launch of World's First Infusion Set with Wear up to Seven Days to Help Reduce Burden for People with Diabetes
DUBLIN, April 14, 2021 -- (Healthcare Sales & Marketing Network) -- Medtronic plc (NYSE: MDT), the global leader in medical technology, today introduced in select European countries the Medtronic Extended infusion set — the first and only infusion set tha... Devices, Drug Delivery, Product Launch Medtronic, Extended Infusion Set, diabetes (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 14, 2021 Category: Pharmaceuticals Source Type: news

OncoSec Receives CE Mark Certification for its Commercial Electroporation Device "GenPulse(TM)" for the Treatment of Solid Tumors
CE mark enables commercialization of GenPulse™ in EU PENNINGTON, N.J. and SAN DIEGO, April 14, 2021 -- (Healthcare Sales & Marketing Network) -- OncoSec Medical Incorporated (NASDAQ:ONCS) (the "Company" or "OncoSec"), a biotechnolog... Devices, Oncology, Regulatory OncoSec Medical, GenPulse, electroporation, gene delivery device (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 14, 2021 Category: Pharmaceuticals Source Type: news

HotSpot Therapeutics Appoints Timothy Reilly as Chief Development Officer
Drug development leader brings extensive expertise in clinical and overall development strategy and execution across a wide range of therapeutic areas BOSTON, April 14, 2021 -- (Healthcare Sales & Marketing Network) -- HotSpot Therapeutics, Inc, a biot... Biopharmaceuticals, Personnel HotSpot Therapeutics, allosteric medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 14, 2021 Category: Pharmaceuticals Source Type: news

GlobalMed Introduces the TotalExam(R) Lite, the Next Generation of Digital General Exam Cameras and Otoscopes for Telemedicine
The TotalExam® Lite Camera Combines State of the Art Imaging in a Lightweight, Economical Package SCOTTSDALE, Ariz., April 14, 2021 -- (Healthcare Sales & Marketing Network) -- GlobalMed, an international provider of virtual health solutions, is pr... Devices, Product Launch GlobalMed, TotalExam Lite, otoscope (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 14, 2021 Category: Pharmaceuticals Source Type: news

Ventris Announces Launch of Next Generation Biologic, Allocell(R) AF
NEWPORT BEACH, Calif., April 14, 2021 -- (Healthcare Sales & Marketing Network) -- Ventris Medical, a privately held orthobiologics company focused on design, development and commercialization of allografts and synthetic products for improving patient out... Devices, Orthopaedic, Product Launch Ventris Medical, Allocell AF, allograft (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 14, 2021 Category: Pharmaceuticals Source Type: news

Ortho's VITROS(R) SARS-CoV-2 Antigen Test for High-Volume COVID-19 Testing Receives CE Mark; Allows for More Convenient Sample Collection and Expanded Viral Transport Media
RARITAN, N.J., April 13, 2021 -- (Healthcare Sales & Marketing Network) -- Ortho Clinical Diagnostics (Nasdaq: OCDX), one of the world's largest pure-play in vitro diagnostics companies, today announced it received CE Marking for its VITROS® SARS-CoV-... Diagnostics, Regulatory Ortho Clinical Diagnostics, VITROS, SARS-CoV-2, Antigen Test (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 13, 2021 Category: Pharmaceuticals Source Type: news

Theseus Pharmaceuticals Debuts with $100M Series B Raise to Develop Pan-Variant Kinase Inhibitors
Founded by pioneers of targeted oncology, Theseus is developing best-in-class TKIs to overcome cancer resistance Presentation at AACR highlights THE-630, the Company's next-generation inhibitor for KIT-mutant gastrointestinal stromal tumors (GIST) BO... Biopharmaceuticals, Oncology, Venture Capital Theseus Pharmaceuticals, targeted oncology (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 13, 2021 Category: Pharmaceuticals Source Type: news

Bausch and Lomb Announces Statistically Significant Topline Results From The First Phase 3 Trial Of NOV03 (perfluorohexyloctane) In Dry Eye Disease Associated With Meibomian Gland Dysfunction
All Primary and Secondary Endpoints Were Achieved LAVAL, QC and HEIDELBERG, Germany, April 13, 2021 -- (Healthcare Sales & Marketing Network) -- Bausch & Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) ("... Biopharmaceuticals, Ophthalmology Bausch Health Companies, Bausch & Lomb, Novaliq, perfluorohexyloctane (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 13, 2021 Category: Pharmaceuticals Source Type: news

Diogo Rau to join Lilly as Senior Vice-President and Chief Information and Digital Officer
INDIANAPOLIS, April 12, 2021 -- (Healthcare Sales & Marketing Network) -- Eli Lilly and Company (NYSE: LLY) announced today that Diogo Rau will join the company on May 17, 2021 as senior vice-president and chief information and digital officer. Rau succee... Biopharmaceuticals, Personnel Eli Lilly (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 13, 2021 Category: Pharmaceuticals Source Type: news

Memic Innovative Surgery Raises $96 Million
Financing led by Peregrine Ventures and Ceros with participation from OurCrowd and Accelmed Funding primarily supports commercialization of Hominis® surgical robot in the United States following FDA De Novo marketing authorization TEL AVIV, Israe... Devices, Surgery, Venture Capital Memic Innovative Surgery, Hominis, robotic surgery (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2021 Category: Pharmaceuticals Source Type: news

Grünenthal acquires Mestex AG and its Phase-III-ready investigational medicine MTX-071 for the treatment of pain associated with osteoarthritis of the knee
With the acquisition of Mestex AG, Grünenthal secures global rights for an attractive late-stage asset that could offer an innovative therapy option for millions of patients affected by pain related to osteoarthritis of the knee. MTX-071 (resinife... Biopharmaceuticals, Mergers & Acquisitions Grünenthal, Mestex AG, resiniferatoxin, osteoarthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2021 Category: Pharmaceuticals Source Type: news

U.S. FDA Grants De Novo Clearance for First and Only Artificial Intelligence System for Colonoscopy; Medtronic Launches GI Genius(TM) Intelligent Endoscopy Module
The GI Genius™ Module Assists Physicians in Detecting Pre-Cancerous Growths; Potentially Addressing 19 Million Colonoscopies Annually Transformative AI Colorectal Cancer Prevention Platform Expands Medtronic Capabilities in Medical Technology Data Analy... Devices, Gastroenterology, FDA, Product Launch Medtronic, Cosmo Pharmaceuticals, GI Genius, intelligent endoscopy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2021 Category: Pharmaceuticals Source Type: news

Cosmo announces FDA approval of GI Genius(TM) intelligent endoscopy module, its revolutionary Artificial Intelligence device for lesion detection during colonoscopy
DUBLIN, April 12, 2021 -- (Healthcare Sales & Marketing Network) -- Cosmo Pharmaceuticals NV (SIX: COPN) today announced the FDA approval of GI Genius™ intelligent endoscopy system, its revolutionary device for lesion detection during colonoscopy. The ... Devices, Gastroenterology, FDA Cosmo Pharmaceuticals, Medtronic, GI Genius, intelligent endoscopy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 12, 2021 Category: Pharmaceuticals Source Type: news

Activ Surgical Announces FDA Clearance for ActivSight Intraoperative Imaging Module for Enhanced Surgical Visualization
Surgeons Gain Access to Real-Time Intraoperative Visual Data and Images to Improve Patient Outcomes BOSTON, April 9, 2021 -- (Healthcare Sales & Marketing Network) -- Activ Surgical™, a digital surgery pioneer, today announced the U.S. Food and Drug Ad... Devices, Surgery, FDA Activ Surgical, robotic surgery, Intraoperative Imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 9, 2021 Category: Pharmaceuticals Source Type: news

NeuX Technologies Announces Dr. John Pecora as Vice President of Business Development
TAMPA, Fla., April 9, 2021 -- (Healthcare Sales & Marketing Network) -- NeuX Technologies, a leading provider of advanced medical technology for the health, wellness, fitness and human performance markets, is excited to announce Dr. John Pecora has joined... Devices, Personnel NeuX Technologies, Interactive Neuromuscular Stimulation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 9, 2021 Category: Pharmaceuticals Source Type: news

Abbott Receives CE Mark Approval for Next-Generation TriClip(TM) Device, Offering New Innovations for Tricuspid Heart Valve Repair
New enhancements to first-of-its-kind device uniquely developed for the difficult-to-treat tricuspid valve Next-generation therapy offers enhanced leaflet grasping feature and new clip sizes to fit each patient's complex tricuspid valve anatomy TriCl... Devices, Interventional, Cardiology, Regulatory Abbott, TriClip, Transcatheter, Tricuspid Valve Repair, Tricuspid Valve (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 8, 2021 Category: Pharmaceuticals Source Type: news

Crown Aesthetics Proudly Announces New Indication For Treatment Of Neck Wrinkles For FDA-Cleared Microneedling System, SkinPen(R) Precision
SkinPen Expands Treatment Offerings with New FDA Clearance DALLAS, April 8, 2021 -- (Healthcare Sales & Marketing Network) -- Crown Aesthetics, a division of Crown Laboratories, Inc. and the US leader in Microneedling Technology, announced today that t... Devices, Dermatology, FDA Bellus Medical, Crown Aesthetics, SkinPen, Microneedling, Neck Wrinkles (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 8, 2021 Category: Pharmaceuticals Source Type: news

Imvax Appoints Sean Hemingway as Chief Operating Officer
Imvax expands its leadership team as the emerging biotech company continues to grow PHILADELPHIA, April 8, 2021 -- (Healthcare Sales & Marketing Network) -- Imvax, Inc., an emerging oncology leader that is revolutionizing immunotherapy for patients wit... Biopharmaceuticals, Oncology, Personnel Imvax, neo-antigen immunotherapy, glioblastoma multiforme (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 8, 2021 Category: Pharmaceuticals Source Type: news

Lilly and Incyte announce results from the Phase 3 COV-BARRIER study of baricitinib in hospitalized COVID-19 patients
Randomized, double-blind, placebo-controlled study of 1,525 patients did not meet statistical significance on primary endpoint (progression to non-invasive ventilation or invasive mechanical ventilation or death) Data showed 38% reduction in mortality b... Biopharmaceuticals Eli Lilly, Incyte , baricitinib, OLUMIANT, COVID-19 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 8, 2021 Category: Pharmaceuticals Source Type: news

MolecuLight Announces the Appointment of 11 Global Distributors
Distributors' Extensive Support and Technical Expertise will Meet Growing Global Demand for the MolecuLight i:X® Fluorescence Wound Imaging Device TORONTO, April 8, 2021 -- (Healthcare Sales & Marketing Network) - MolecuLight Inc., the leader in po... Devices, Wound Care, Distribution MolecuLight, MolecuLight i:X, fluorescence imaging (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 8, 2021 Category: Pharmaceuticals Source Type: news

Chemence Medical Receives FDA Approval for Exofin Fusion(R) Redesign
Medical technologies manufacturer improves patient care with enhanced skin closure system ALPHARETTA, Ga., April 7, 2021 -- (Healthcare Sales & Marketing Network) -- Chemence Medical, a world leader in medical cyanoacrylate devices and products, announ... Devices, Surgery, FDA Chemence Medical, Exofin Fusion, skin closure (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 7, 2021 Category: Pharmaceuticals Source Type: news

MedShape Appoints Greg Berlet, MD as Chief Medical Officer
New position demonstrates company's commitment to advancing clinical innovation in orthopedics ATLANTA, April 7, 2021 -- (Healthcare Sales & Marketing Network) -- MedShape, Inc., the orthopedic industry leader in promoting active, adaptive healing tech... Devices, Orthopaedic, Personnel MedShape, DynaNail, NiTiNOL (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 7, 2021 Category: Pharmaceuticals Source Type: news

FDA Approves Bausch and Lomb ClearVisc(TM) Dispersive Ophthalmic Viscosurgical Device
New OVD Offers Exceptional Corneal Protection, Visibility During Ophthalmic Surgery LAVAL, QC, April 7, 2021 -- (Healthcare Sales & Marketing Network) -- Bausch & Lomb, a leading global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC... Devices, Ophthalmology, FDA Bausch & Lomb, ClearVisc , ophthalmic viscosurgical device (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 7, 2021 Category: Pharmaceuticals Source Type: news

LumiThera Announces Top Line Data in the European Multi-Center, LIGHTSITE II Clinical Study to Treat Dry Age-Related Macular Degeneration
SEATTLE, April 7, 2021 -- (Healthcare Sales & Marketing Network) -- LumiThera Inc., a commercial stage medical device company delivering photobiomodulation (PBM) treatment for ocular disorders and disease, today announced positive findings in its LIGHTSIT... Devices, Ophthalmology LumiThera , photobiomodulation, Age-Related Macular Degeneration (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 7, 2021 Category: Pharmaceuticals Source Type: news

nanoMesh(TM) LLC (a subsidiary of Exogenesis Corporation) Announces Completion Filing of a Second Pre-Marketing Notification Application (510(k)) with the US Food and Drug Administration (FDA)
Innovative Soft Tissue Repair Implant Possesses a Unique Nanometer-level Surface Texture BILLERICA, Mass., April 6, 2021 -- (Healthcare Sales & Marketing Network) -- nanoMesh™ LLC, a subsidiary of Exogenesis Corporation, announced today that it has suc... Devices, Surgery, FDA Exogenesis, nanoMesh, hernia repair (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 6, 2021 Category: Pharmaceuticals Source Type: news

Eclipse Launches DermaFlex Line of Microcannulas
DALLAS, April 6, 2021 -- (Healthcare Sales & Marketing Network) -- Eclipse, a US-based medical device manufacturer, is excited to introduce the DermaFlex line of microcannulas. Now available for sale domestically, DermaFlex is an advancement in the des... Devices, Dermatology, Product Launch Eclipse, DermaFlex, microcannula (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 6, 2021 Category: Pharmaceuticals Source Type: news

Mineralys Therapeutics Closes $40 Million Series A Funding
Financing Co-led by HBM Healthcare Investments and Samsara BioCapital Food and Drug Administration Accepts Investigational New Drug Application for MLS-101 and Advances to Phase 2 Proof-of-Concept Clinical Trial Company Announces Jon Congleton as Chi... Biopharmaceuticals, Cardiology, Venture Capital, Personnel Mineralys Therapeutics, aldosterone synthase, hypertension (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 6, 2021 Category: Pharmaceuticals Source Type: news

Seelos Therapeutics Announces a Strategic Device Partnership with AptarGroup, Inc.
Strategic Device Partnership Allows Seelos to Use Aptar Pharma's Bidose (BDS) Liquid System Device with the SLS-002 Program (Intranasal Racemic Ketamine) Strategic Device Partnership Covers the Use of the BDS Liquid System for Intranasal Delivery of SLS... Biopharmaceuticals, Devices, Drug Delivery Seelos Therapeutics, AptarGroup, Bidose, intranasal ketamine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 6, 2021 Category: Pharmaceuticals Source Type: news

IRRAS Announces Collaboration with Aarhus University Hospital, Scandinavian Leader in Neurosurgery, to Advance Use of IRRAflow
The collaboration with Aarhus University's neurosurgical team will evaluate IRRAflow during the treatment of Intraventricular Hemorrhage (IVH) and assessment of brain compliance STOCKHOLM, April 6, 2021 -- (Healthcare Sales & Marketing Network) -- IRRA... Devices, Neurosurgery, Monitoring IRRAS AB, IRRAflow catheter, Hummingbird ICP Monitoring (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 6, 2021 Category: Pharmaceuticals Source Type: news

NLS Pharmaceutics Appoints Silvia Panigone, Ph.D. As Chief Operating Officer
STANS, Switzerland, April 5, 2021 -- (Healthcare Sales & Marketing Network) -- NLS Pharmaceutics Ltd. (Nasdaq: NLSP, NLSPW) ("NLS" or the "Company"), a Swiss clinical-stage pharmaceutical company focused on the discovery and developmen... Biopharmaceuticals, Neurology, Personnel NLS Pharmaceutics, Quilience, narcolepsy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 5, 2021 Category: Pharmaceuticals Source Type: news

IceCure Medical Granted FDA Breakthrough Device Designation for ProSense(R) Cryoablation System
Treatment for patients with T1 invasive breast cancer and/or breast cancer for patients not suitable for surgical alternatives included in the indications being reviewed CAESAREA, Israel, April 5, 2021 -- (Healthcare Sales & Marketing Network) -- IceC... Devices, Oncology, FDA IceCure Medical, ProSense , cryoablation (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 5, 2021 Category: Pharmaceuticals Source Type: news

Ionis initiates Phase 3 trial of novel antisense medicine to treat leading cause of juvenile-onset ALS
ION363, the first medicine to specifically target FUS-ALS, is among Ionis' wholly owned assets the company plans to commercialize ALS portfolio now includes four clinical-stage investigational antisense medicines designed to treat the root causes of gen... Biopharmaceuticals, Neurology Ionis Pharmaceuticals, amyotrophic lateral sclerosis, FUS-ALS (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 5, 2021 Category: Pharmaceuticals Source Type: news

S4 Medical Closes Series A Financing
CLEVELAND, April 2, 2021 -- (Healthcare Sales & Marketing Network) -- S4 Medical moves a step closer in developing the most comprehensive solution to protect the esophagus from thermal injury during catheter ablation procedures for atrial fibrillation (AF... Devices, Venture Capital S4 Medical, esolution catheter (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 2, 2021 Category: Pharmaceuticals Source Type: news

FDA Grants Breakthrough Therapy Designation for Taiho Oncology's Futibatinib for Treatment of Advanced Cholangiocarcinoma
PRINCETON, N.J. and TOKYO, April 1, 2021 -- (Healthcare Sales & Marketing Network) -- Taiho Oncology, Inc. and Taiho Pharmaceutical Co., Ltd. today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation (BT... Biopharmaceuticals, Oncology, FDA Taiho Oncology, Taiho Pharmaceutical, futibatinib, cholangiocarcinoma (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 1, 2021 Category: Pharmaceuticals Source Type: news

SkinMedica(R) Launches Neck Correct Cream for Neck and Décolleté
Revolutionary, Clinically Proven Product Addresses Multi-Factorial Causes & Symptoms of Neck Aging IRVINE, Calif., April 1, 2021 -- (Healthcare Sales & Marketing Network) -- Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the laun... Biopharmaceuticals, Dermatology, Product Launch AbbVie, SkinMedica, Neck Correct (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 1, 2021 Category: Pharmaceuticals Source Type: news

BD to Invest $65 Million for Key Supply Chain Infrastructure in Tucson, Arizona to Increase Resiliency of U.S. Medical Device Supply
TUCSON, Ariz., April 1, 2021 -- (Healthcare Sales & Marketing Network) -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today it will invest $65 million to construct a state-of-the-art facility in T... Devices BD (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 1, 2021 Category: Pharmaceuticals Source Type: news

United Therapeutics Announces FDA Approval and Launch of Tyvaso(R) for the Treatment of Pulmonary Hypertension Associated with Interstitial Lung Disease
First and only approved therapy in the United States for patients with PH-ILD, a serious, life-threatening disease with potentially more than 30,000 patients in need FDA approval based on data from the INCREASE clinical trial PH-ILD is the second FDA... Biopharmaceuticals, FDA, Product Launch United Therapeutics, Tyvaso, treprostinil, pulmonary hypertension (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - April 1, 2021 Category: Pharmaceuticals Source Type: news

Zimmer Biomet Announces Key Updates to Company's Executive Leadership Team
Lori Winkler Appointed as Chief Human Resources Officer Sang Yi Promoted to Group President, Asia Pacific with Oversight for Ex-U.S. Channel Management & Portfolio Rationalization Strategy WARSAW, Ind., March 31, 2021 -- (Healthcare Sales & Marketing... Devices, Orthopaedic, Personnel Zimmer Biomet (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 31, 2021 Category: Pharmaceuticals Source Type: news

CTI BioPharma Announces Completion of Rolling Submission of New Drug Application (NDA) for Pacritinib in Myelofibrosis Patients with Severe Thrombocytopenia
Commercial Preparations Underway to Support Potential Approval and Launch of Pacritinib in the United States in 2021 SEATTLE, March 31, 2021 -- (Healthcare Sales & Marketing Network) -- CTI BioPharma Corp. (Nasdaq: CTIC) today announced that it has com... Biopharmaceuticals, FDA CTI BioPharma, pacritinib, myelofibrosis, thrombocytopenia (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 31, 2021 Category: Pharmaceuticals Source Type: news

Biom Therapeutics Receives Orphan Drug Status for BIO017 from the U.S. FDA for the treatment of Angelman Syndrome
There is currently no effective treatment for the 25,000 children diagnosed in the U.S. with Angelman syndrome, a rare pediatric epilepsy. BIO017 showed efficacy in preclinical Angelman animal models and preliminary clinical studies SARASOTA, Fla., Marc... Biopharmaceuticals, Neurology, FDA Biom Therapeutics, Angelman syndrome (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 30, 2021 Category: Pharmaceuticals Source Type: news

Expansion of Raystation Treatment Planning System at The Inova Schar Cancer Institute
STOCKHOLM, March 30, 2021 -- (Healthcare Sales & Marketing Network) -- RaySearch Laboratories AB (publ) announces an order from the Inova Department of Advanced Radiation Oncology and Proton Therapy in Alexandria and Fairfax regions of Virginia, significa... Devices, Oncology RaySearch Laboratories, RayStation, treatment planning, radiotherapy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 30, 2021 Category: Pharmaceuticals Source Type: news

PTC Therapeutics Announces the European Approval of Evrysdi(TM) for the Treatment of Spinal Muscular Atrophy
First and only at home treatment approved for SMA Proven efficacy in adults and children with SMA 2 months and older SOUTH PLAINFIELD, N.J., March 30, 2021 -- (Healthcare Sales & Marketing Network) -- PTC Therapeutics, Inc. (NASDAQ: PTCT) today anno... Biopharmaceuticals, Regulatory PTC Therapeutics, Evrysdi, risdiplam, spinal muscular atrophy (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 30, 2021 Category: Pharmaceuticals Source Type: news

COVID-19 Antibody Tests For Variants Now Available Worldwide
ROCKVILLE, Md., March 29, 2021 -- (Healthcare Sales & Marketing Network) -- Meso Scale Diagnostics, LLC. (MSD) today announced the commercial release of its V-PLEX® Serology Panels for SARS-CoV-2 variants. The release includes panels that test for imp... Diagnostics, Product Launch Meso Scale Diagnostics, V-PLEX, SARS-CoV-2, COVID-19 (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 29, 2021 Category: Pharmaceuticals Source Type: news

Phoenix Molecular Designs Appoints Biotech Powerhouse, Michael Varney, Ph.D., to its Advisory Board
SAN DIEGO, California and VANCOUVER, BC, March 29, 2021 -- (Healthcare Sales & Marketing Network) - Phoenix Molecular Designs (PhoenixMD), a company on a mission to help thousands of patients and their families battling triple negative breast cancer (TNBC... Biopharmaceuticals, Oncology, Personnel Phoenix Molecular Designs, triple negative breast cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 29, 2021 Category: Pharmaceuticals Source Type: news

Constipation treatment Vibrant raises $7.5 million led by Unorthodox Ventures
Sequoia Capital invests for fourth time as treatment continues third round of FDA trials YOKNEAM ILLIT, Israel, March 26, 2021 -- (Healthcare Sales & Marketing Network) -- Vibrant, a leading developer of gastrointestinal treatments, today announced the... Devices, Gastroenterology, Venture Capital Vibrant Ltd, vibrating capsule (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 26, 2021 Category: Pharmaceuticals Source Type: news

European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin
Enfortumab vedotin to be reviewed under accelerated assessment for the treatment of locally advanced or metastatic urothelial cancer TOKYO and BOTHELL, Wash., March 26, 2021 -- (Healthcare Sales & Marketing Network) -- Astellas Pharma Inc. (TSE: 4503, ... Biopharmaceuticals, Oncology, Regulatory Astellas Pharma, enfortumab vedotin, urothelial cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - March 26, 2021 Category: Pharmaceuticals Source Type: news